Landmark PALOMA and MARIPOSA Studies Reveal the Impact of Amivantamab Alone and Combined with Lazertinib in Advanced NSCLC
Mutations in the epidermal growth factor receptor (*EGFR*) gene are frequently detected in non-small cell lung cancer (NSCLC). The most common *EGFR* mutations include deletions in exon 19 (Ex19del) and point L858R mutations in exon 21. Among uncommon mutations, exon 20 insertions (Ex20ins) account...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2024-06-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2024.20.150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|